Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,231.00
  • Today's Change-46.00 / -3.60%
  • Shares traded183.57k
  • 1 Year change-11.50%
  • Beta0.4832
Data delayed at least 20 minutes, as of Aug 05 2022 17:06 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Forecasts data is unavailable for this security.

Consensus recommendation

  • 19-Aug-21
  • 19-May-22
  • 16-Jun-22
  • 14-Jul-22
  • 04-Aug-22
Select bar for recommendation details.

Share price forecast

The 9 analysts offering 12 month price targets for Abcam Plc have a median target of 1,420.00, with a high estimate of 1,800.00 and a low estimate of 1,260.00. The median estimate represents a 15.35% increase from the last price of 1,231.00.

Earnings history & estimates

Abcam Plc reported annual 2021 earnings of 32.90 per share on Mar 14, 2022.
Average growth rate+19.25%
More ▼

Revenue history & estimates

Abcam plc had revenues for the full year 2021 of 462.90m. This was 78.04% above the prior year's results.
Average growth rate+24.24%
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.